Compound Evidence File
#EC-2026-0514
Methylene Blue
Filed under Oral Tablets. The bureau holds 178 laboratory returns for this compound from 66 distinct subjects. Scores below are per-subject aggregates; open a subject row for the underlying evidence.
Cross-Index
Subjects Shipping This Compound
66 SUBJECTS| Subject | Grade | Samples | Mean | Min | Max | First seen | Last seen |
|---|---|---|---|---|---|---|---|
| Tianjin Finder Chemical TFCCASE #VI-2026-0693 | A | 7 | 10.0 | 9.9 | 10.0 | 14 Nov 2025 | 16 Apr 2026 |
| WuXi TIDESCASE #VI-2026-0335 | A | 5 | 10.0 | 9.9 | 10.0 | 3 Feb 2026 | 13 Jul 2026 |
| HomopeptideCASE #VI-2026-0760 | A | 4 | 10.0 | 9.9 | 10.0 | 23 May 2026 | 23 May 2026 |
| Shanghai ERP BiotechnologyCASE #VI-2026-0936 | A | 4 | 10.0 | 9.9 | 10.0 | 3 Feb 2026 | 2 Jul 2026 |
| Shanghai Sigma AudleyCASE #VI-2026-0505 | A | 4 | 10.0 | 9.9 | 10.0 | 14 Feb 2026 | 10 Jul 2026 |
| GenScript PeptidesCASE #VI-2026-0860 | A | 4 | 10.0 | 9.9 | 10.0 | 4 Feb 2026 | 3 Aug 2026 |
| PolyPeptide GroupCASE #VI-2026-0143 | A | 4 | 10.0 | 9.9 | 10.0 | 3 Apr 2026 | 6 Aug 2026 |
| QYAOBIOCASE #VI-2026-0861 | A | 3 | 10.0 | 9.9 | 10.0 | 15 Dec 2025 | 24 May 2026 |
| JEEP PeptidesCASE #VI-2026-0457 | A | 3 | 10.0 | 9.9 | 10.0 | 9 Nov 2025 | 10 Jun 2026 |
| BachemCASE #VI-2026-0314 | A | 3 | 10.0 | 10.0 | 10.0 | 27 Nov 2025 | 24 Jun 2026 |
| Hubei JianxiangCASE #VI-2026-0048 | A | 3 | 10.0 | 10.0 | 10.0 | 12 Apr 2026 | 26 Jun 2026 |
| Mokemei BiotechnologyCASE #VI-2026-0540 | A | 3 | 10.0 | 9.9 | 10.0 | 17 Mar 2026 | 28 Jun 2026 |
| Hybio PharmaceuticalCASE #VI-2026-0065 | A | 3 | 10.0 | 9.9 | 10.0 | 9 May 2026 | 15 Jul 2026 |
| Sigma-AldrichCASE #VI-2026-0829 | A | 3 | 10.0 | 9.9 | 10.0 | 1 Aug 2026 | 18 Aug 2026 |
| AsymchemCASE #VI-2026-0091 | A | 3 | 10.0 | 10.0 | 10.0 | 6 Mar 2026 | 17 Jul 2026 |
| AmbioPharmCASE #VI-2026-0177 | A | 3 | 10.0 | 9.9 | 10.0 | 12 May 2026 | 19 Aug 2026 |
| Shanghai Wibson BiotechnologyCASE #VI-2026-0379 | A | 2 | 10.0 | 10.0 | 10.0 | 16 Jan 2026 | 6 May 2026 |
| Trusted PeptideCASE #VI-2026-0499 | X | 1 | 10.0 | 10.0 | 10.0 | 9 Jun 2025 | 9 Jun 2025 |
| Sangon BioCASE #VI-2026-0671 | A | 4 | 9.9 | 9.9 | 10.0 | 3 Apr 2026 | 24 Apr 2026 |
| Flourishglobal PeptideCASE #VI-2026-0630 | A | 4 | 9.9 | 9.9 | 10.0 | 16 Jan 2026 | 17 May 2026 |
| Kerui PeptidesCASE #VI-2026-0626 | A | 3 | 9.9 | 9.9 | 10.0 | 25 Nov 2025 | 5 Jun 2026 |
| Chinese Peptide CompanyCASE #VI-2026-0184 | A | 2 | 9.9 | 9.9 | 9.9 | 19 Mar 2026 | 16 May 2026 |
| Thermo Fisher ScientificCASE #VI-2026-0142 | A | 2 | 9.9 | 9.9 | 10.0 | 25 Jun 2026 | 19 Jul 2026 |
| SinoPepCASE #VI-2026-0387 | A | 2 | 9.9 | 9.9 | 10.0 | 20 Dec 2025 | 7 Jul 2026 |
| Shandong Shengyuan Peptide TechnologyCASE #VI-2026-0634 | X | 1 | 9.7 | 9.7 | 9.7 | 6 May 2025 | 6 May 2025 |
| Peptide TechnologiesCASE #VI-2026-0694 | X | 1 | 9.6 | 9.6 | 9.6 | 17 Dec 2024 | 17 Dec 2024 |
| Qingdao Sigma Chemical QSCCASE #VI-2026-0538 | A | 8 | 8.8 | 6.8 | 9.9 | 21 May 2026 | 21 May 2026 |
| Glbiochem (Shanghai)CASE #VI-2026-0704 | A | 5 | 8.7 | 7.4 | 10.0 | 24 May 2026 | 24 May 2026 |
| Champion PeptideCASE #VI-2026-0909 | X | 1 | 8.3 | 8.3 | 8.3 | 2 Apr 2025 | 2 Apr 2025 |
| Shanghai Sigma Audley SSACASE #VI-2026-0486 | A | 4 | 8.2 | 6.8 | 10.0 | 24 May 2026 | 24 May 2026 |
| Shanghai BaojuCASE #VI-2026-0233 | X | 1 | 8.0 | 8.0 | 8.0 | 24 Apr 2025 | 24 Apr 2025 |
| Xianhong Tong XHT PeptidesCASE #VI-2026-0997 | X | 1 | 7.8 | 7.8 | 7.8 | 3 Jun 2025 | 3 Jun 2025 |
| Limitless Life NootropicsCASE #VI-2026-0980 | X | 2 | 7.7 | 7.0 | 8.3 | 24 Apr 2025 | 24 May 2026 |
| Platinum CryoCASE #VI-2026-0406 | X | 1 | 7.6 | 7.6 | 7.6 | 28 Mar 2025 | 28 Mar 2025 |
| Xingtai Lesda TechnologyCASE #VI-2026-0381 | X | 1 | 7.5 | 7.5 | 7.5 | 17 Dec 2024 | 17 Dec 2024 |
| Wuhan Wansheng Bio (WWB)CASE #VI-2026-0594 | A | 6 | 7.4 | 6.0 | 8.2 | 23 May 2026 | 23 May 2026 |
| HK PeptidesCASE #VI-2026-0140 | X | 8 | 7.4 | 5.7 | 9.3 | 28 Mar 2025 | 24 May 2026 |
| Yabang PeptideCASE #VI-2026-0148 | X | 1 | 7.4 | 7.4 | 7.4 | 2 Apr 2025 | 2 Apr 2025 |
| LiliPeptideCASE #VI-2026-0695 | X | 13 | 7.2 | 2.9 | 10.0 | 3 Jun 2025 | 19 Jan 2026 |
| Mai PeptideCASE #VI-2026-0769 | X | 5 | 7.2 | 4.9 | 10.0 | 13 Jun 2025 | 24 May 2026 |
| Nantong Guangyuan Chemical GYCCASE #VI-2026-0284 | A | 2 | 7.0 | 6.4 | 7.5 | 24 May 2026 | 24 May 2026 |
| ScienceCASE #VI-2026-0636 | X | 1 | 7.0 | 7.0 | 7.0 | 16 Mar 2025 | 16 Mar 2025 |
| LN PeptidesCASE #VI-2026-0781 | X | 1 | 6.7 | 6.7 | 6.7 | 2 Apr 2025 | 2 Apr 2025 |
| Laicuinuo LCNCASE #VI-2026-0223 | X | 1 | 6.3 | 6.3 | 6.3 | 13 Feb 2025 | 13 Feb 2025 |
| Shenzhen Loga Tech LG LOGACASE #VI-2026-0920 | X | 2 | 6.2 | 4.5 | 7.8 | 6 May 2025 | 21 May 2026 |
| Peptide SciencesCASE #VI-2026-0867 | X | 3 | 6.0 | 4.5 | 7.4 | 6 May 2025 | 24 May 2026 |
| NextechLabsCASE #VI-2026-0285 | X | 2 | 5.8 | 5.0 | 6.6 | 3 Jun 2025 | 21 May 2026 |
| Zhejiang Yichenkang BiotechnologyCASE #VI-2026-0269 | X | 5 | 5.7 | 3.5 | 8.0 | 3 Jul 2025 | 21 May 2026 |
| Haikou Mingheng TechnologyCASE #VI-2026-0250 | X | 1 | 5.7 | 5.7 | 5.7 | 2 Apr 2025 | 2 Apr 2025 |
| LipeptidesCASE #VI-2026-0863 | X | 1 | 5.6 | 5.6 | 5.6 | 2 Apr 2025 | 2 Apr 2025 |
| TydesCASE #VI-2026-0493 | X | 3 | 5.4 | 3.8 | 7.2 | 25 Apr 2025 | 25 May 2026 |
| CellupepCASE #VI-2026-0888 | X | 1 | 5.3 | 5.3 | 5.3 | 27 Feb 2025 | 27 Feb 2025 |
| Alpha-GenCASE #VI-2026-0905 | X | 2 | 5.2 | 3.7 | 6.8 | 20 Jun 2025 | 21 May 2026 |
| Prime PeptidesCASE #VI-2026-0696 | X | 1 | 5.2 | 5.2 | 5.2 | 3 Jun 2025 | 3 Jun 2025 |
| Modern AminosCASE #VI-2026-0635 | X | 1 | 5.0 | 5.0 | 5.0 | 25 Apr 2025 | 25 Apr 2025 |
| Shaanxi Dideu MedichemCASE #VI-2026-0499 | X | 1 | 5.0 | 5.0 | 5.0 | 3 Jun 2025 | 3 Jun 2025 |
| Changan District Sheng Peptide TradingCASE #VI-2026-0341 | X | 1 | 4.2 | 4.2 | 4.2 | 6 May 2025 | 6 May 2025 |
| Loti LabsCASE #VI-2026-0171 | X | 2 | 4.1 | 3.0 | 5.2 | 17 Dec 2024 | 23 May 2026 |
| Pharma Grade PeptidesCASE #VI-2026-0208 | X | 1 | 4.1 | 4.1 | 4.1 | 13 Feb 2025 | 13 Feb 2025 |
| Oasis PeptidesCASE #VI-2026-0404 | X | 1 | 4.0 | 4.0 | 4.0 | 2 Jul 2025 | 2 Jul 2025 |
| Guangzhou Lengiuanhuang CosmeticsCASE #VI-2026-0228 | X | 1 | 2.7 | 2.7 | 2.7 | 14 Jan 2025 | 14 Jan 2025 |
| Peptides For SaleCASE #VI-2026-0614 | X | 2 | 2.5 | 0.0 | 5.1 | 20 Jun 2025 | 24 May 2026 |
| Wuhan Newtop BiotechCASE #VI-2026-0676 | X | 1 | 0.7 | 0.7 | 0.7 | 14 Jan 2025 | 14 Jan 2025 |
| NuLife PeptidesCASE #VI-2026-0980 | X | 1 | 0.0 | 0.0 | 0.0 | 9 Jun 2025 | 9 Jun 2025 |
| Guangzhou Yuao TradingCASE #VI-2026-0787 | X | 1 | 0.0 | 0.0 | 0.0 | 16 Mar 2025 | 16 Mar 2025 |
| SubQ SocietyCASE #VI-2026-0716 | X | 1 | 0.0 | 0.0 | 0.0 | 13 Feb 2025 | 13 Feb 2025 |
Open any subject to view the batch-level evidence for Methylene Blue alone.